WO2013120529A1 - New calicivirus - Google Patents
New calicivirus Download PDFInfo
- Publication number
- WO2013120529A1 WO2013120529A1 PCT/EP2012/052706 EP2012052706W WO2013120529A1 WO 2013120529 A1 WO2013120529 A1 WO 2013120529A1 EP 2012052706 W EP2012052706 W EP 2012052706W WO 2013120529 A1 WO2013120529 A1 WO 2013120529A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- calicivirus
- seq
- sample
- virus
- amino acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/00088—Details for redistribution
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/16011—Caliciviridae
Definitions
- the present invention relates to a new calicivirus being a causative agent for diarrhea.
- the present invention further relates to (in vitro) methods for the detection of the present calicivirus in a sample and to a kit of parts allowing the detection of the present calicivirus in a samp1e .
- Diarrhea is a common cause of morbidity and mortality and remains the second leading cause of death around the world for children under 5 years of age,
- This object of the present invention is met by providing a new diarrhea causing calicivirus virus as defined in the appended claims.
- this object of the present invention is met, according to a first aspect, by providing a calicivirus wherein the virus comprises a nucleotide sequence encoding a VP1 capsid protein comprising an amino acid sequence as defined in SEQ ID No. 1, or encoding a VP1 capsid protein comprising an amino acid sequence with at least 70%, preferably at least 80%, more preferably at least 95% and most preferably at least 99% sequence identity with SEQ ID No. 1, and wherein the present virus is a causative agent for diarrhea.
- Caliciviruses are non-enveloped, positive-stranded RNA viruses with a -6.4-8.4 kb non-segmented polyadenylated genome.
- Caliciviridae consists of five recognized genera, Norovirus, Sapovirus, Lagovirus, Vesivirus and Nebovirus, and two proposed genera, Recovirus and Valovirus.
- Caliciviruses cause a wide spectrum of diseases in animals, among which pigs, reptiles, amphibians, cattle, cats and chickens and are an important etiological agent in viral gastroenteritis in humans.
- RNA genome of caliciviruses encodes a polyprotein precursor for non-structural proteins, and two structural capsid proteins, VP1 and VP2.
- the genomes of caliciviruses differ in genome organization and contain two or three open-reading frames (ORFs)
- sequence identity is defined as the number of identical consecutive aligned nucleotides, or amino acids, over the full length of the present sequences divided by the number of nucleotides, or amino acids, of the full length of the present sequences and multiplied by 100%.
- the new calicivirus identified herein is further characterised by comprising a nucleotide sequence encoding a VP2 capsid protein comprising an amino acid sequence as defined in SEQ ID No. 2 or encoding a VP2 capsid protein comprising an amino acid sequence with at least 70%,
- the new calicivirus identified herein is further characterised by comprising a nucleotide sequence encoding a polyprotein comprising an amino acid sequence as defined in SEQ ID No. 3 or encoding a polyprotein comprising an amino acid sequence having at least 70%, preferably at least 80%, more preferably at least 95% and most preferably at least 99% sequence identity with SEQ ID No. 3.
- the new calicivirus identified herein is further characterised by a nucleotide sequence comprising SEQ ID No. 4 or a nucleotide sequence having at least 70%, preferably at least 80%, more preferably at least 95% and most preferably at least 99% sequence identity with SEQ ID No. 4
- the present calicivirus preferably is a human calicivirus more
- nucleotide sequences disclosed herein allow identification of the present viruses using commonly known techniques for nucleotide (RNA or DNA) or protein detection
- the present invention according to a second aspect, relates to the use of one or more sequences selected from the group consisting of SEQ ID Nos. 1 to 4 for establishing the presence of a diarrhea causing calicivirus in a sample, preferably a stool sample, most preferably a human stool sample.
- protein analysis comprises ELISA.
- nucleotide analysis comprises PCR, rtPCR or NASBA.
- present viruses are a causative agent of diarrhea and the amino acid and
- kits of parts for detecting the presence of a diarrhea causing calicivirus in a sample preferably a stool sample, most preferably a human stool sample
- the kits comprise:
- Figure 1 shows a schematic outline of the strategies used for PCR amplification of human calicivirus Bangladesh/289/2007.
- the upper panel shows a schematic representation of the human calicivirus Bangladesh/289/2007 genome.
- the boxes represent the ORFs encoding the calicivirus proteins. Indicated are the 5' -end with a cap (circle) and the poly (A) - tail (An) .
- the boxes in gray extrapolated based on the genome composition of other caliciviruses .
- the lower panels show a schematic outline of the RT-PCR assays employed to amplify calicivirus
- This panel shows the genome organization of caliciviruses in the genera Reco-, Vesi-, Valo-, Nebo-, Noro-, Sapo-, and Lagovirus for comparison with the new human calicivirus Bangladesh/289/2007.
- the numbers indicate the nucleotide positions according to the virus genome for which the Genbank accession number is indicated.
- Figure 2 shows phylogenetic trees of the amino acid
- Phylograms were generated using MEGA5, with the Neighbor- oining method with p-distance and 1,000 bootstrap replicates. Significant bootstrap values and Genbank accession numbers are shown.
- sequence-independent amplification was performed on partially purified viral nucleic acid from diarrhea samples from Bangladesh.
- the samples included were 105 diarrheic stool specimens from patients enrolled in the 2% systematic routine surveillance system at the Clinical Research and Service Centre of the International Centre for Diarrheal Disease Research, Bangladesh (ICDDRB) from 2007. These samples were pre-screened negative for adenovirus and rotavirus A, using Taqman EZ RT-PCR Core Reagents (Applied Biosystems) and rotavirus primers RVNSP3R and RVNSP3F and probe 5' -FAM-AGTTAAAAGCTAACACTGTCAAA- TAMRA- 3 ' and the Taqman Universal Mastermix (Applied Biosystems) for the adenovirus primers according to the manufacturer' s
- the pyrosequencing reads were trimmed for adaptor and primer sequences and more than 725,000 trimmed reads were assembled using de novo assembly in CLC Genomics
- Sequences were classified into eukaryotic viruses, phages, bacteria, and eukaryotes based on the taxonomic origin of the best-hit sequence using MEGAN 4.40. An E value of 0.001 was used as the cut-off value of significant virus hits. Most of the identified sequences were of eukaryotic or bacterial origin or did not have any significant hits to nucleotide or amino acid sequences in Genbank. The largest proportion of fecal virus-related sequences in human
- a novel mammalian virus from the family Caliciviridae was identified in sample 289 by near full- length genome sequencing using random amplification in combination with next-generation sequencing, specific RT- PCRs, and 3' RACE PCR and was designated virus
- Bangladesh/289/2007 belongs to the genus Recovirus.
- a diagnostic real time human recovirus PCR was performed on 1614 diarrhea samples from patients enrolled in the 2% systematic routine surveillance system at the ICDDRB, Bangladesh from years 2007, 2008, and 2009.
- RT-PCR grade viral RNA was extracted from an aliquot of the samples using Magnapure LC total nucleic acid isolation kit (Roche) , according to the manufacturer's instructions.
- VS666 5 ' -CGATTGGCCAGTTTACAGC-3 '
- probe VS664 5' FAM- CACTGGATTGCCTCAAC-3' TAMPA
- Taqman EZ RT-PCR Core Reagents Applied Biosystems
- the pathogens that were tested for are Shigella, Aeromonas, Vibrio cholera, Campylobacter, and Salmonella species.
- samples were screened for Giardia lamblia, Entamoeba histolytica, Cryptosporidium, Ascaris lumbricoides, Cyclospora cayetanensis, and Isospora belli, adenoviruses and group A rotaviruses.
- the virus from patient 289 is the described human calicivirus Bangladesh/289/2007 in this study.
- the human calicivirus Bangladesh/289/2007 is considered a new type species of the genus Recovirus based on the facts that
- Tulane and Recovirus Bangladesh/289/2007 is larger than that between the two type species of the genus Lagovirus
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The present invention relates to a not previously known calicivirus being a causative agent for diarrhea. The present invention further relates to methods for the detection of the present calicivirus in a sample and to a kit of parts allowing the detection of the present calicivirus in a sample. Specifically, the present invention relates to caliciviruses characterised in the virus comprises a nucleic acid sequence encoding a VP1 capsid protein comprising an amino acid sequence as defined in SEQ ID No. 1, or encoding a VP1 capsid protein comprising an amino acid sequence with at least 70%, preferably at least 80%, more preferably at least 95% and most preferably at least 99% sequence identity with SEQ ID No. 1, and in that said virus is a causative agent for diarrhea.
Description
NEW CALICIVIRUS
Description The present invention relates to a new calicivirus being a causative agent for diarrhea. The present invention further relates to (in vitro) methods for the detection of the present calicivirus in a sample and to a kit of parts allowing the detection of the present calicivirus in a samp1e .
Diarrhea is a common cause of morbidity and mortality and remains the second leading cause of death around the world for children under 5 years of age,
especially in low and middle-income countries.
For otherwise healthy individuals suffering from diarrhea medical attention is not always necessary. However, weakened individuals suffering from diarrhea, such as individuals already suffering from other diseases and especially individuals with a compromised immune system, often require immediate medical attention or
hospitalization.
Many causative agents of diarrhea have been identified including viruses, bacteria and parasites.
Especially considering the divergent nature of diarrhea causing pathogens, establishing the nature of the pathogen is important for diagnosis and treatment. For example, if the pathogen is a virus, antibiotic treatment will
inherently not be effective. Similar observations can be made for anti-parasite medicaments being not effective against viruses and bacteria. Especially with respect to viral diarrhea causing pathogens knowledge is limited.
In recent years, random amplification in combination with (next-generation) sequencing methods has
been employed in many types of samples such as human and animal blood, respiratory secretions, and fecal material, which resulted in the identification of many novel viruses. Despite these multiple viral metagenomic studies available, a large proportion of viral diarrhea cases, and especially human viral diarrhea cases, remains undiagnosed, i.e. the causative viral agent is not known.
Considering the potential morbidity and mortality of diarrhea, there is a need in the art to identify diarrhea causing pathogens, and especially diarrhea causing viruses, allowing (early) diagnosis, epidemic confinement and
control, and/or appropriate treatment.
It is an object of the present invention, amongst other objects, to meet the above need in the art.
This object of the present invention, amongst other objects, is met by providing a new diarrhea causing calicivirus virus as defined in the appended claims.
Specifically, this object of the present invention, amongst other objects, is met, according to a first aspect, by providing a calicivirus wherein the virus comprises a nucleotide sequence encoding a VP1 capsid protein comprising an amino acid sequence as defined in SEQ ID No. 1, or encoding a VP1 capsid protein comprising an amino acid sequence with at least 70%, preferably at least 80%, more preferably at least 95% and most preferably at least 99% sequence identity with SEQ ID No. 1, and wherein the present virus is a causative agent for diarrhea.
Caliciviruses are non-enveloped, positive-stranded RNA viruses with a -6.4-8.4 kb non-segmented polyadenylated genome.
The family Caliciviridae consists of five recognized genera, Norovirus, Sapovirus, Lagovirus,
Vesivirus and Nebovirus, and two proposed genera, Recovirus and Valovirus.
Caliciviruses cause a wide spectrum of diseases in animals, among which pigs, reptiles, amphibians, cattle, cats and chickens and are an important etiological agent in viral gastroenteritis in humans.
The RNA genome of caliciviruses encodes a polyprotein precursor for non-structural proteins, and two structural capsid proteins, VP1 and VP2. The genomes of caliciviruses differ in genome organization and contain two or three open-reading frames (ORFs)
The present invention relates to nucleotide and amino acid sequences characterised by a percentage sequence identity. Sequence identity as used herein is defined as the number of identical consecutive aligned nucleotides, or amino acids, over the full length of the present sequences divided by the number of nucleotides, or amino acids, of the full length of the present sequences and multiplied by 100%. For example, a sequence with 80% identity to SEQ ID No. 1 comprises over the total length of 550 amino acids of SEQ ID No. 1 440 identical aligned consecutive amino acids, i.e., 440/550 * 100% = 80%.
According to a preferred embodiment of the present invention, the new calicivirus identified herein is further characterised by comprising a nucleotide sequence encoding a VP2 capsid protein comprising an amino acid sequence as defined in SEQ ID No. 2 or encoding a VP2 capsid protein comprising an amino acid sequence with at least 70%,
preferably at least 80%, more preferably at least 95% and most preferably at least 99% sequence identity with SEQ ID No. 2.
According to another preferred embodiment of the present invention, the new calicivirus identified herein is
further characterised by comprising a nucleotide sequence encoding a polyprotein comprising an amino acid sequence as defined in SEQ ID No. 3 or encoding a polyprotein comprising an amino acid sequence having at least 70%, preferably at least 80%, more preferably at least 95% and most preferably at least 99% sequence identity with SEQ ID No. 3.
According to yet another preferred embodiment of the present invention, the new calicivirus identified herein is further characterised by a nucleotide sequence comprising SEQ ID No. 4 or a nucleotide sequence having at least 70%, preferably at least 80%, more preferably at least 95% and most preferably at least 99% sequence identity with SEQ ID No. 4
According to the present invention, the present calicivirus preferably is a human calicivirus more
preferably belonging to the genus Recovirus.
Considering that the present viruses are a
causative agent of diarrhea and the amino acid and
nucleotide sequences disclosed herein allow identification of the present viruses using commonly known techniques for nucleotide (RNA or DNA) or protein detection, the present invention, according to a second aspect, relates to the use of one or more sequences selected from the group consisting of SEQ ID Nos. 1 to 4 for establishing the presence of a diarrhea causing calicivirus in a sample, preferably a stool sample, most preferably a human stool sample.
According to a preferred embodiment of this second aspect of the present invention, protein analysis comprises ELISA.
According to another preferred embodiment of this second aspect of the present invention, nucleotide analysis comprises PCR, rtPCR or NASBA.
Again considering that the present viruses are a causative agent of diarrhea and the amino acid and
nucleotide sequences discloses herein allow identification of the present viruses, the present invention, according to a third aspect, relates to kits of parts for detecting the presence of a diarrhea causing calicivirus in a sample, preferably a stool sample, most preferably a human stool sample, the kits comprise:
means for detecting the presence of one or more sequences selected from the group
consisting of SEQ ID Nos. 1 to 4 in said sample; and
instructions for use.
The present invention will be further detailed in the following example of preferred embodiments of the invention. In the example, reference is made to figures wherein :
Figure 1: shows a schematic outline of the strategies used for PCR amplification of human calicivirus Bangladesh/289/2007. (A) The upper panel shows a schematic representation of the human calicivirus Bangladesh/289/2007 genome. The boxes represent the ORFs encoding the calicivirus proteins. Indicated are the 5' -end with a cap (circle) and the poly (A) - tail (An) . The boxes in gray extrapolated based on the genome composition of other caliciviruses . The lower panels show a schematic outline of the RT-PCR assays employed to amplify calicivirus
Bangladesh/289/2007 sequences, using random
amplification, degenerate PCR and 3' RACE PCR. The orientations and positions of the oligonucleotides on the calicivirus genome are shown. (B) This panel
shows the genome organization of caliciviruses in the genera Reco-, Vesi-, Valo-, Nebo-, Noro-, Sapo-, and Lagovirus for comparison with the new human calicivirus Bangladesh/289/2007. The numbers indicate the nucleotide positions according to the virus genome for which the Genbank accession number is indicated.
Figure 2: shows phylogenetic trees of the amino acid
sequences of the partial polyprotein sequence (A) ,
VP1 (B) and VP2 (C) capsid proteins of selected representative caliciviruses and the newly identified human recovirus Bangladesh/289/2007. Phylograms were generated using MEGA5, with the Neighbor- oining method with p-distance and 1,000 bootstrap replicates. Significant bootstrap values and Genbank accession numbers are shown.
Example
In an effort to identify unknown human viruses in the enteric tract, sequence-independent amplification was performed on partially purified viral nucleic acid from diarrhea samples from Bangladesh.
The samples included were 105 diarrheic stool specimens from patients enrolled in the 2% systematic routine surveillance system at the Clinical Research and Service Centre of the International Centre for Diarrheal Disease Research, Bangladesh (ICDDRB) from 2007. These samples were pre-screened negative for adenovirus and rotavirus A, using Taqman EZ RT-PCR Core Reagents (Applied Biosystems) and rotavirus primers RVNSP3R and RVNSP3F and probe 5' -FAM-AGTTAAAAGCTAACACTGTCAAA- TAMRA- 3 ' and the
Taqman Universal Mastermix (Applied Biosystems) for the adenovirus primers according to the manufacturer' s
instructions .
Large scale molecular virus screening, based on host nucleic acid depletion, viral nucleic acid isolation, sequence-independent amplification and next-generation sequencing with a 454 GS Junior Instrument (Roche) was performed as described previously and by the manufacturer.
The pyrosequencing reads were trimmed for adaptor and primer sequences and more than 725,000 trimmed reads were assembled using de novo assembly in CLC Genomics
Workbench 4.5.1 and analyzed according to BLASTn (contigs and singletons) and BLASTx searches (contigs) .
Sequences were classified into eukaryotic viruses, phages, bacteria, and eukaryotes based on the taxonomic origin of the best-hit sequence using MEGAN 4.40. An E value of 0.001 was used as the cut-off value of significant virus hits. Most of the identified sequences were of eukaryotic or bacterial origin or did not have any significant hits to nucleotide or amino acid sequences in Genbank. The largest proportion of fecal virus-related sequences in human
diarrhea samples from Bangladesh in 2007 was related to known bacteriophages and mammalian viruses.
A novel mammalian virus from the family Caliciviridae was identified in sample 289 by near full- length genome sequencing using random amplification in combination with next-generation sequencing, specific RT- PCRs, and 3' RACE PCR and was designated virus
Bangladesh/289/2007. The genome organization of calicivirus Bangladesh/289/2007 is most closely related to that of viruses in the genus Norovirus, with ORF2 encoding VP1 overlapping with ORF1 (Figure 1) .
The partial polyprotein precursor sequence and complete VP1 and VP2 capsid proteins were aligned to the corresponding sequences of selected representative
caliciviruses . Divergence analysis using p-distance
demonstrated that the human calicivirus Bangladesh/289/2007 was 43.2%, 57.8%, and 50.7% divergent on the amino acid level in the polyprotein, VP1, and VP2, respectively, from its most closest relative, Tulane virus, a recently
characterized calicivirus from rhesus macaques in the proposed genus Recovirus (Table 1) .
Table 1: Percentage amino acid diversity of human
calicivirus Bangladesh with representative caliciviruses of other genera.
Calicivirus genus3 Strain Accession no. NS polyproteinb VP1 VP2
Norovirus Norwalk M87661 72. .7 74. 9 80.0
Southampton L07418 74. .1 85. 0 81.3
Sapovirus Manchester X86560 80. .2 82. 9 85.3
PEC Cowden AF182760 83. .1 81. 8 86.7
Vesivirus FCV CFI68 U13992 82. .3 83. 4 85.3
SMSV 1 U15301 81. .9 87. 7 90.7
Lagovirus RHDV FRG M67473 82. .6 84. 0 88.0
EBHSV GD Z69620 83. .2 84. 0 93.3
Nebovirus BEC NB AY082891 81. .0 84. 0 90.7
Newbury 1 DQ013304 80. .6 84. 0 89.3
Recovirus Tulane EU391643 43. .2 57. 8 50.7
Valovirus AB104 FJ355930 65. .3 61. 5 81.3 a Valovirus and Recovirus are two tentative genera not yet accepted by the International Committee on Taxonomy of Viruses.
b All polyprotein sequences were aligned without the capsid protein encoding sequences .
Neighbor- oining phylogenetic trees were generated using the partial polyprotein and complete VPl and VP2 proteins, which underlined the divergence analysis (Figure 2) . Thus, it was concluded that human calicivirus
Bangladesh/289/2007 belongs to the genus Recovirus.
To obtain insight in the prevalence of recoviruses in humans, a diagnostic real time human recovirus PCR was performed on 1614 diarrhea samples from patients enrolled in the 2% systematic routine surveillance system at the ICDDRB, Bangladesh from years 2007, 2008, and 2009. RT-PCR grade viral RNA was extracted from an aliquot of the samples using Magnapure LC total nucleic acid isolation kit (Roche) , according to the manufacturer's instructions.
Human recoviruses were amplified by real time RT- PCR using primers VS665 ( 5' -CAAGGTGATTGTGAATGACCAACT-3 ) ,
VS666 ( 5 ' -CGATTGGCCAGTTTACAGC-3 ' ) and probe VS664 (5' FAM- CACTGGATTGCCTCAAC-3' TAMPA) , and the Taqman EZ RT-PCR Core Reagents (Applied Biosystems), using the cycling program 50°C for 2 min, 60°C for 30 min, 95°C for 5 min and 50 cycles of 95°C for 20 seconds and 59°C for 1 min.
Real time RT-PCR amplicons were recovirus- confirmed by sequence analysis. In addition to the sample positive for human calicivirus Bangladesh/289/2007, five other samples were positive for a human recovirus with high homology to human calicivirus Bangladesh/289/2007 (Table 2), indicating that human recovirus Bangladesh infects humans. The clinical data indicate that all six patients with a recovirus infection presented with 6 to >21 watery stools in the first 24h. Vomiting occurred in four patients and fever was present in two. The age of the patients ranged from 3 months to 50 years. Other clinical and demographic data are represented in Table 2.
Table 2 : Clinical data of patients positive for human
Recovirus Bangladesh.
Patient Age Sex Collection Diarrhea Temperature Duration3 No.stoolb Vomitingc Abd. Paind Condition6 Pathogens'
201 23 M 2007 Watery Fever < 1 day 11-15 < 10 Yes Lethargic No
289a 25 M 2007 Watery Normal < 1 day 6-10 < 10 Yes Lethargic No
445 20 M 2007 Watery Normal 1-3 days 11-15 0 Yes Normal No
507 50 F 2007 Watery Normal < 1 day 6-10 < 10 No Drowsy Vibrio cholera
809 0 M 2008 Watery Normal 4-6 days > 21 < 10 No Lethargic Rotavirus A
1084 1 M 2008 Watery Fever 1-3 days 6-10 0 Yes Normal Adenoviru sISalmonella a Disease duration in days.
b The number of passing stools in the previous 24 hours.
c Times of vomiting in the previous 24 hours.
d Abdominal pain.
e Overall condition of the pacient.
'The pathogens that were tested for are Shigella, Aeromonas, Vibrio cholera, Campylobacter, and Salmonella species.
In addition, the samples were screened for Giardia lamblia, Entamoeba histolytica, Cryptosporidium, Ascaris lumbricoides, Cyclospora cayetanensis, and Isospora belli, adenoviruses and group A rotaviruses.
The virus from patient 289 is the described human calicivirus Bangladesh/289/2007 in this study.
Three human recovirus-positive patients showed evidence for co-infecting pathogens that are known to cause diarrhea in humans, such as rotavirus A, adenovirus, Vibrio cholera, and/or Salmonella species, the other three did not, suggesting that human recovirus Bangladesh may be involved in causing diarrhea.
Conclusions
A large proportion of human diarrhea cases remains undiagnosed, despite multiple viral metagenomic studies in human stool aimed at identifying new etiological agents.
This observation, in combination with the fact that it cannot be predicted when and where ( re- ) emerging viruses
will appear in the human population, urged to perform a metagenomic viral inventory in 105 diarrhea samples from Bangladesh, which led to the identification of a new
calicivirus .
Although no species demarcation criteria have been defined for the family Caliciviridae by the International Committee on the Taxonomy of Viruses, the new virus was classified human calicivirus Bangladesh/289/2007 in the proposed genus Recovirus, based primarily on phylogenetic analyses .
The human calicivirus Bangladesh/289/2007 is considered a new type species of the genus Recovirus based on the facts that
(i) the genetic distance between Recovirus
Tulane and Recovirus Bangladesh/289/2007 is larger than that between the two type species of the genus Lagovirus,
(ii) the genome organization of Recovirus Tulane and Bangladesh/289/2007 differs, and
(iii) Recovirus Tulane and Bangladesh/289/2007 were identified in different host species.
Claims
1. Calicivirus characterised in that said virus comprises a nucleotide sequence encoding a VP1 capsid protein comprising an amino acid sequence as defined in SEQ ID No. 1, or encoding a VP1 capsid protein comprising an amino acid sequence with at least 70%, preferably at least 80%, more preferably at least 95% and most preferably at least 99% sequence identity with SEQ ID No. 1, and in that said virus is a causative agent for diarrhea.
2. Calicivirus according to claim 1, wherein said virus further comprises a nucleotide sequence encoding a VP2 capsid protein comprising an amino acid sequence as defined in SEQ ID No. 2 or encoding a VP2 capsid protein comprising an amino acid sequence with at least 70%, preferably at least 80%, more preferably at least 95% and most preferably at least 99% sequence identity with SEQ ID No. 2. 3. Calicivirus according to claim 1 or claim 2, wherein said virus further comprises a nucleotide sequence encoding a polyprotein comprising an amino acid sequence as defined in SEQ ID No. 3 or encoding a polyprotein comprising an amino acid sequence having at least 70%, preferably at least 80%, more preferably at least 95% and most preferably at least 99% sequence identity with SEQ ID No.
3.
4. Calicivirus according to any of the claims 1 to 3, wherein said virus is further characterised by a
nucleotide sequence comprising SEQ ID No. 4 or a nucleic acid sequence having at least 70%, preferably at least 80%, more preferably at least 95% and most preferably at least 99% sequence identity with SEQ ID No. 4 24
5. Calicivirus according to any of the claims 1 to
4, wherein said virus is a human calicivirus.
6. Calicivirus according to any of the claims 1 to
5, wherein said virus belongs to the genus Recovirus.
7. Use of one or more sequences selected from the group consisting of SEQ ID Nos. 1 to 4 for establishing the presence of a diarrhea causing calicivirus in a sample.
8. Use according to claim 7, wherein said sample is a stool sample.
9. Use according to claim 7 or claim 8, wherein said sample is a human sample.
10. Use according to any of the claims 7 to 9, wherein said establishing comprises protein analysis or RNA analysis.
11. Use according to claim 10, wherein said protein analysis comprises ELISA.
12. Use according to claim 10, wherein said RNA analysis comprises PCR, rtPCR or NASBA.
13. Use according to claim 10, wherein said DNA analysis comprises PCR or NASBA.
14. Kit of parts for detecting the presence of a diarrhea causing calicivirus in a sample, preferably a stool sample, most preferably a human stool sample comprising: 25 means for detecting the presence of one or more sequences selected from the group consisting of SEQ ID Nos. 1 to 4 in said sample; and
instructions for use.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2012/052706 WO2013120529A1 (en) | 2012-02-16 | 2012-02-16 | New calicivirus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2012/052706 WO2013120529A1 (en) | 2012-02-16 | 2012-02-16 | New calicivirus |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2013120529A1 true WO2013120529A1 (en) | 2013-08-22 |
Family
ID=45808777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2012/052706 WO2013120529A1 (en) | 2012-02-16 | 2012-02-16 | New calicivirus |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2013120529A1 (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010055134A1 (en) * | 2008-11-13 | 2010-05-20 | Riboxx Gmbh | Rna detection method |
-
2012
- 2012-02-16 WO PCT/EP2012/052706 patent/WO2013120529A1/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010055134A1 (en) * | 2008-11-13 | 2010-05-20 | Riboxx Gmbh | Rna detection method |
Non-Patent Citations (1)
Title |
---|
T. FARKAS ET AL: "Characterization of a Rhesus Monkey Calicivirus Representing a New Genus of Caliciviridae", JOURNAL OF VIROLOGY, vol. 82, no. 11, 1 June 2008 (2008-06-01), pages 5408 - 5416, XP055024651, ISSN: 0022-538X, DOI: 10.1128/JVI.00070-08 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Delwart | Viral metagenomics | |
Lima et al. | The intestinal virome of malabsorption syndrome-affected and unaffected broilers through shotgun metagenomics | |
King et al. | Development of a TaqMan® PCR assay with internal amplification control for the detection of African swine fever virus | |
Kraberger et al. | Characterisation of a diverse range of circular replication-associated protein encoding DNA viruses recovered from a sewage treatment oxidation pond | |
Sonntag et al. | New adenovirus in bats, Germany | |
Soma et al. | Detection of Norovirus and Sapovirus from diarrheic dogs and cats in Japan | |
Reuter et al. | Identification of a novel astrovirus in domestic sheep in Hungary | |
Sauvage et al. | Viral metagenomics applied to blood donors and recipients at high risk for blood-borne infections | |
Geng et al. | Phylogenetic analysis of the full genome of rabbit hepatitis E virus (rbHEV) and molecular biologic study on the possibility of cross species transmission of rbHEV | |
Jackwood et al. | Molecular studies on suspect very virulent infectious bursal disease virus genomic RNA samples | |
Lange et al. | Virus isolate from carp: genetic characterization reveals a novel picornavirus with two aphthovirus 2A-like sequences | |
Turan et al. | Detection and molecular analysis of bovine enteric norovirus and nebovirus in Turkey | |
Silva et al. | High frequency of porcine norovirus infection in finisher units of Brazilian pig-production systems | |
Tochetto et al. | Viral DNA genomes in sera of farrowing sows with or without stillbirths | |
Medici et al. | Broadly reactive nested reverse transcription-PCR using an internal RNA standard control for detection of noroviruses in stool samples | |
CN111394515A (en) | L AMP primer group for detecting canine parvovirus, fluorescence visualization rapid kit and method | |
Keum et al. | Porcine noroviruses and sapoviruses on Korean swine farms | |
Park et al. | Molecular detection and characterization of unclassified bovine enteric caliciviruses in South Korea | |
Al-Mubarak et al. | Cocirculation of four infectious bronchitis virus lineages in broiler chickens in the Eastern Region of Saudi Arabia from 2012 to 2014 | |
Yinda et al. | A single bat species in Cameroon harbors multiple highly divergent papillomaviruses in stool identified by metagenomics analysis | |
CA2424333C (en) | Method of detecting norwalk-like virus (gii) | |
Liu et al. | The analysis of oral and fecal virome detects multiple novel emerging viruses in snakes | |
JP6027023B2 (en) | Compositions and methods for identifying and distinguishing viral components of multivalent transport fever vaccines | |
Park et al. | Development of SYBR Green real-time RT-PCR for rapid detection, quantitation and diagnosis of unclassified bovine enteric calicivirus | |
US7202032B2 (en) | Method of detecting Norwalk-like virus (GI) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12707499 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12707499 Country of ref document: EP Kind code of ref document: A1 |